DekaBank Deutsche Girozentrale’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $139M | Hold |
1,747,168
| – | – | 0.24% | 100 |
|
|
2026
Q1 | $142M | Hold |
1,747,168
| – | – | 0.24% | 100 |
|
|
2025
Q4 | $164M | Hold |
1,747,168
| – | – | 0.28% | 80 |
|
|
2025
Q3 | $134M | Hold |
1,747,168
| – | – | 0.23% | 104 |
|
|
2025
Q2 | $137M | Sell |
1,747,168
-214,041
| -11% | -$16M | 0.24% | 99 |
|
|
2025
Q1 | $138M | Buy |
1,961,209
+214,041
| +12% | +$15.3M | 0.27% | 91 |
|
|
2024
Q4 | $131M | Hold |
1,747,168
| – | – | 0.24% | 96 |
|
|
2024
Q3 | $116M | Buy |
1,747,168
+64,613
| +4% | +$4.69M | 0.21% | 114 |
|
|
2024
Q2 | $157M | Sell |
1,682,555
-278,654
| -14% | -$24.7M | 0.28% | 80 |
|
|
2024
Q1 | $188M | Sell |
1,961,209
-315,362
| -14% | -$26.5M | 0.35% | 66 |
|
|
2023
Q4 | $174M | Buy |
2,276,571
+767,997
| +51% | +$53.4M | 0.36% | 66 |
|
|
2023
Q3 | $105M | Buy |
1,508,574
+99,535
| +7% | +$8M | 0.24% | 99 |
|
|
2023
Q2 | $131M | Buy |
1,409,039
+113,614
| +9% | +$9.87M | 0.29% | 81 |
|
|
2023
Q1 | $106M | Sell |
1,295,425
-173,159
| -12% | -$13.6M | 0.27% | 96 |
|
|
2022
Q4 | $110M | Buy |
1,468,584
+1,010,261
| +220% | +$77.9M | 0.29% | 84 |
|
|
2022
Q3 | $38.1M | Sell |
458,323
-25,889
| -5% | -$2.49M | 0.11% | 195 |
|
|
2022
Q2 | $45.8M | Buy |
484,212
+85,681
| +21% | +$8.87M | 0.13% | 172 |
|
|
2022
Q1 | $47.2M | Buy |
398,531
+18,392
| +5% | +$2.06M | 0.12% | 187 |
|
|
2021
Q4 | $49.8M | Buy |
380,139
+51,697
| +16% | +$6.03M | 0.12% | 176 |
|
|
2021
Q3 | $37.4M | Sell |
328,442
-54,056
| -14% | -$6.17M | 0.1% | 188 |
|
|
2021
Q2 | $39.3M | Buy |
382,498
+5,253
| +1% | +$495K | 0.11% | 187 |
|
|
2021
Q1 | $31M | Sell |
377,245
-44,600
| -11% | -$3.77M | 0.1% | 197 |
|
|
2020
Q4 | $38.1M | Buy |
421,845
+57,665
| +16% | +$4.78M | 0.14% | 154 |
|
|
2020
Q3 | $28.2M | Buy |
364,180
+98,135
| +37% | +$7.66M | 0.13% | 160 |
|
|
2020
Q2 | $18.1M | Buy |
266,045
+7,178
| +3% | +$510K | 0.11% | 139 |
|
|
2020
Q1 | $17M | Buy |
258,867
+130,341
| +101% | +$9.4M | 0.13% | 128 |
|
|
2019
Q4 | $10.1M | Sell |
128,526
-34,452
| -21% | -$2.69M | 0.06% | 225 |
|
|
2019
Q3 | $11.9M | Sell |
162,978
-25,029
| -13% | -$1.76M | 0.07% | 233 |
|
|
2019
Q2 | $11.7M | Buy |
188,007
+960
| +0.5% | +$58K | 0.06% | 302 |
|
|
2019
Q1 | $9.09M | Buy |
187,047
+44,340
| +31% | +$2.53M | 0.05% | 326 |
|
|
2018
Q4 | $7.24M | Sell |
142,707
-44,340
| -24% | -$2.24M | 0.05% | 312 |
|
|
2018
Q3 | $9.09M | Buy |
187,047
+85,065
| +83% | +$4.16M | 0.05% | 329 |
|
|
2018
Q2 | $5.07M | Sell |
101,982
-38,535
| -27% | -$1.8M | 0.03% | 394 |
|
|
2018
Q1 | $6.56M | Sell |
140,517
-349,533
| -71% | -$15.2M | 0.04% | 351 |
|
|
2017
Q4 | $19M | Hold |
490,050
| – | – | 0.15% | 157 |
|
|
2017
Q3 | $19M | Sell |
490,050
-76,686
| -14% | -$2.92M | 0.15% | 157 |
|
|
2017
Q2 | $22.3M | Buy |
566,736
+16,311
| +3% | +$595K | 0.18% | 138 |
|
|
2017
Q1 | $17.3M | Sell |
550,425
-98,787
| -15% | -$3.09M | 0.16% | 136 |
|
|
2016
Q4 | $20.1M | Buy |
649,212
+414,600
| +177% | +$13.4M | 0.21% | 109 |
|
|
2016
Q3 | $9.33M | Buy |
234,612
+82,092
| +54% | +$3.09M | 0.1% | 205 |
|
|
2016
Q2 | $4.94M | Buy |
152,520
+54,000
| +55% | +$1.85M | 0.06% | 304 |
|
|
2016
Q1 | $2.91M | Buy |
98,520
+18,540
| +23% | +$512K | 0.03% | 403 |
|
|
2015
Q4 | $2.13M | Sell |
79,980
-900
| -1% | -$23.4K | 0.02% | 450 |
|
|
2015
Q3 | $1.88M | Buy |
80,880
+978
| +1% | +$23.6K | 0.02% | 460 |
|
|
2015
Q2 | $1.91M | Sell |
79,902
-34,308
| -30% | -$774K | 0.02% | 457 |
|
|
2015
Q1 | $2.73M | Sell |
114,210
-7,680
| -6% | -$172K | 0.03% | 397 |
|
|
2014
Q4 | $2.63M | Buy |
121,890
+36,000
| +42% | +$723K | 0.03% | 416 |
|
|
2014
Q3 | $1.48M | Sell |
85,890
-28,152
| -25% | -$444K | 0.02% | 465 |
|
|
2014
Q2 | $1.67M | Buy |
114,042
+53,292
| +88% | +$722K | 0.03% | 442 |
|
|
2014
Q1 | $748K | Sell |
60,750
-181,800
| -75% | -$2.1M | 0.01% | 519 |
|
|
2013
Q4 | $2.67M | Buy |
242,550
+173,304
| +250% | +$1.95M | 0.04% | 283 |
|
|
2013
Q3 | $794K | Sell |
69,246
-4,554
| -6% | -$53.3K | 0.01% | 470 |
|
|
2013
Q2 | $822K | Buy |
+73,800
| New | +$874K | 0.02% | 398 |
|
Other funds holding EW
WT
DekaBank Deutsche Girozentrale's EW Position: Q2 2026 in Review
DekaBank Deutsche Girozentrale held its Edwards Lifesciences (EW) position steady in Q2 2026 at 1,747,168 shares worth $139M. The position accounts for 0.24% of the portfolio, ranked #100.
DekaBank Deutsche Girozentrale first reported a position in EW in Q2 2013 and has held it in 53 quarters since. The position peaked at $188M in Q1 2024. 774 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- DekaBank Deutsche Girozentrale held 1,747,168 shares of Edwards Lifesciences worth $139M as of Q2 2026.
- DekaBank Deutsche Girozentrale left its Edwards Lifesciences share count unchanged in Q2 2026.
- Edwards Lifesciences made up 0.24% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #100 holding.
- DekaBank Deutsche Girozentrale first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
- DekaBank Deutsche Girozentrale's Edwards Lifesciences position peaked at $188M in Q1 2024.
- 774 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.